Privacy-First DTC & DTP Marketing for Eli Lilly

From Ad Click to Fulfilled Script—With Privacy Built In

Eli Lilly no longer has to choose between protecting patient data and tracking the full LillyDirect journey. Freshpaint governs sensitive health data at the point of collection—preventing leaks to ad platforms while capturing every touchpoint from ad click to telehealth consult and online pharmacy fulfillment.
https://res.cloudinary.com/dhogpnwxa/video/upload/v1768228642/Healthcare_Integrations_fdenv5.mp4
75%
of pharma marketers say compliance risk is increasing.
83%
can't connect website visits to direct-to-patient scripts.
62%
of privacy leaders lack visibility into marketing data flows exposing health data.
250+
healthcare & life science organizations trust Freshpaint.
The Solutions to Eli Lilly's Challenges

Achieve Full-Funnel DTP Measurement Without Compromising Patient Privacy

Marketing and privacy teams both get exactly what they need — speed, full visibility, and compliance — without compromise.
Stop Sensitive Health Data From Reaching Ad Platforms
Freshpaint replaces risky third-party trackers with a privacy-first data layer that automatically de-identifies sensitive health data at the source. Marketing can safely use the ad platforms and analytics tools they need without regulatory risk.

• Safe-by-default architecture strips sensitive health data before any event fires to Meta, Google, or programmatic DSPs.

• Control exactly which data flows to which destinations through a simple interface. Legal and compliance teams approve data sharing at a granular level. No engineering required, no room for human error.

• Full audit trail of what data flows where, for privacy and compliance leadership and legal review.

Learn More
Track the Full LillyDirect Journey — From Ad Click to Filled Script
When patients leave LillyDirect for telehealth visits and pharmacy fulfillment, attribution breaks. Freshpaint’s cross-domain identity resolution reconnects the full journey, linking every ad click to an attended appointment or completed script — compliantly.

• True CAC visibility that connects paid channel spend to the bottom-of-funnel conversion events, like scripts filled, not just site sessions or upper-funnel clicks.

• Multi-touch attribution across the full LillyDirect funnel from awareness through fulfillment.

• Direct-to-patient attribution that doesn't break at the handoff — across LillyDirect's telehealth and pharmacy fulfillment partners, with compliance built in.
Learn More
How Freshpaint Works

A Single Governed Data Layer Built for Eli Lilly

Instead of patching broken tracking, Freshpaint replaces it. One compliant pixel. Privacy controls at the source. Performance signals back to every platform you run.
Replace third-party pixels with one compliant layer

A single Freshpaint pixel replaces every third-party script and tracker. Sensitive health data is automatically filtered before anything leaves your environment. No manual scrubbing, no IT ticket, no compliance review for every new tag.

Send real-time signals back to your ad platforms

Compliant conversion events flow in real time to ad platforms and analytics tools. The optimization signals your campaigns depend on like lookalike audiences, suppression lists, and bid optimization are restored immediately.

Track cross-domain direct-to-patient journeys through partner handoffs

When a patient redirects from your branded site to a telehealth partner or pharmacy fulfillment, the journey doesn't break. Freshpaint stitches together the full funnel across domains — with compliance baked in.

Give compliance the visibility to approve campaigns faster

When privacy and compliance can see exactly what data is collected, where it flows, and how it's governed, they can approve campaigns faster and with confidence. Freshpaint makes compliant growth a shared foundation, not a bottleneck.

Ready To See What Freshpaint Can Unlock For Eli Lilly?
Join leading pharma and med device brands using Freshpaint to track the full direct-to-patient journey, prove marketing ROI, eliminate regulatory risk, and scale DTC growth with confidence.

We'll review your current DTC and DTP infrastructure, pinpoint sensitive health data exposure risks, and map out full-funnel Rx attribution for your campaigns.
Get a Demo
Still deciding?